Publication | Closed Access

Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation

InflammationPsoriatic InflammationAnti-inflammatoryMedicineImmunologyImmune RegulationCell DeathChronic InflammationNlrp3 Inflammasome ActivationInflammasomeClinical DermatologyImmune FunctionNf-κb PathwayDermatologyPsoriatic ArthritisInflammatory DiseaseCell Signaling